Cite
HARVARD Citation
Vande Casteele, N. et al. (n.d.). DOP45 Adequate infliximab exposure during the induction phase is associated with early complete fistula response in patients with fistulizing Crohn's disease: a post-hoc analysis of the ACCENT-2 trial. Journal of Crohn's and colitis. pp. S053-S054. [Online].